Which treatment option is indicated for managing mitral stenosis if medical management is insufficient?

Percutaneous balloon valvuloplasty is considered the appropriate treatment for managing mitral stenosis, especially when medical management, which often includes medications to control heart rate and alleviate symptoms, is insufficient. This minimally invasive procedure involves inflating a balloon within the narrowed mitral valve to increase the valve area and improve blood flow.

The success of this technique is particularly notable in symptomatic patients with significant mitral stenosis, especially those who are younger and have pliable valve tissue. Balloon valvuloplasty can significantly alleviate symptoms such as dyspnea and fatigue, improving overall quality of life without the need for more invasive surgical intervention.

Other treatment options, while relevant in different clinical contexts, do not directly address the structural issue of mitral stenosis in the same way. Surgical valve replacement is typically reserved for cases where balloon valvuloplasty is not successful or feasible. Coronary artery bypass grafting focuses on coronary artery disease and does not involve the mitral valve directly. Anticoagulation therapy may be important for preventing thromboembolic events, particularly in patients with atrial fibrillation, but it does not treat the stenosis itself. Thus, percutaneous balloon valvuloplasty is recognized as the initial intervention when symptoms persist despite